Profile data is unavailable for this security.
About the company
EssilorLuxottica SA is a France-based company specializing in the vision care and eye wear industry. Its operations include Ophthalmic Lenses & Optical Instruments, Eye wear such as Frames and Sunglasses, Retail and Distribution Networks, and Equipment Manufacturing. It designs and produces corrective lenses incorporating technologies for addressing myopia, hypermetropia, and astigmatism. It also manufactures and markets both prescription and non-prescription frames and sunglasses. In addition, EssilorLuxottica develops and supplies machines, tools, and consumables used by prescription laboratories and optical professionals. The Company further offers non-prescription reading glasses, fashion eye wear, and related consumer accessories, as well as selected apparel, footwear, and accessories through its associated brands.
- Revenue in EUR (TTM)28.49bn
- Net income in EUR2.32bn
- Incorporated1993
- Employees200.00k
- LocationEssilorLuxottica SA1-6 rue Paul CezannePARIS 75008FranceFRA
- Phone+33 149774224
- Fax+33 149774420
- Websitehttps://www.essilorluxottica.com/
Mergers & acquisitions
| Acquired company | EL:PAR since announced | Transaction value |
|---|---|---|
| Signifeye Nv | -23.03% | -- |
| Automation & Robotics SA | -14.10% | -- |
| PUcore Co Ltd-Optical Materials Division | -10.05% | 14.22m |
| A-Look Eyewear Sdn Bhd | -10.09% | -- |
| Owl Eyewear Sdn Bhd | -10.09% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Koninklijke Philips NV | 17.84bn | 900.00m | 26.08bn | 64.82k | 28.70 | 2.35 | 12.89 | 1.46 | 0.9434 | 0.9381 | 18.73 | 11.52 | 0.6379 | 3.22 | 4.95 | 275,159.30 | 3.22 | -0.9494 | 4.47 | -1.30 | 45.18 | 44.19 | 5.04 | -1.57 | 0.9405 | 8.12 | 0.4239 | -- | -1.04 | 0.5947 | 206.52 | -1.93 | -5.68 | -- |
| Alcon Inc | 8.80bn | 829.36m | 36.54bn | 25.94k | 43.72 | 1.91 | 18.67 | 4.15 | 1.52 | 1.52 | 16.14 | 34.75 | 0.336 | 1.97 | 5.66 | 308,197.10 | 3.17 | 2.51 | 3.46 | 2.75 | 55.78 | 55.86 | 9.42 | 7.87 | 1.33 | 6.71 | 0.1921 | 18.65 | 4.94 | 8.77 | -3.73 | -- | 3.18 | 25.62 |
| Siemens Healthineers AG | 23.30bn | 2.12bn | 47.53bn | 72.80k | 22.36 | 2.58 | 13.45 | 2.04 | 1.88 | 1.88 | 20.72 | 16.34 | 0.5032 | 3.18 | 3.73 | 319,109.60 | 4.63 | 4.33 | 6.37 | 5.86 | 38.44 | 37.61 | 9.20 | 8.82 | 0.7162 | 10.64 | 0.4426 | 53.94 | 4.53 | 10.08 | 10.40 | 8.73 | 7.99 | 4.56 |
| EssilorLuxottica SA | 28.49bn | 2.32bn | 104.33bn | 200.00k | 45.15 | 2.68 | 18.82 | 3.66 | 4.99 | 4.99 | 61.31 | 83.99 | 0.4446 | 3.43 | 8.26 | 142,455.00 | 3.81 | 3.71 | 4.69 | 4.46 | 59.69 | 61.57 | 8.57 | 9.01 | 0.6966 | 17.40 | 0.2672 | -- | 7.48 | 14.58 | -1.87 | 93.65 | 18.60 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Feb 2026 | 10.85m | 2.34% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 6.31m | 1.36% |
| Capital International Ltd.as of 05 Feb 2026 | 6.12m | 1.32% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 5.87m | 1.27% |
| Capital Research & Management Co. (International Investors)as of 05 Feb 2026 | 5.43m | 1.17% |
| Amundi Asset Management SASU (Investment Management)as of 25 Feb 2026 | 4.60m | 0.99% |
| BlackRock Advisors (UK) Ltd.as of 06 Feb 2026 | 4.59m | 0.99% |
| Fidelity Management & Research Co. LLCas of 05 Feb 2026 | 4.37m | 0.94% |
| Capital Research & Management Co. (World Investors)as of 05 Feb 2026 | 3.59m | 0.77% |
| Geode Capital Management LLCas of 26 Feb 2026 | 3.51m | 0.76% |
